EAGLE, Idaho, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today that effective February 1, 2025, it has acquired three premier senior living facilities in Idaho and Texas. The acquisition in Idaho is subject to a triple net lease with the option to purchase, and the two Texas facilities are subject to a long-term, triple net lease.
These acquisitions reinforce Pennant’s commitment to expanding its national footprint and enhancing the quality of care for its senior residents. These transactions expand Pennant’s operations by 188 units, comprised of both assisted living and memory care services. Pennant has strategically positioned itself to meet the growing demand for senior living services and these acquisitions bolster Pennant’s mission to provide personalized, high-quality care.
“The acquisitions in Idaho and Texas represent another step forward for Pennant as we continue to expand our operations in key markets across the country,” said Brent Guerisoli, Chief Executive Officer of Pennant. “We are dedicated to creating vibrant communities where seniors can thrive, and these facilities are an important addition to our portfolio.”
“As we simultaneously expand our presence in two states, we are excited to bring our expertise and commitment to excellence for the residents of each community,” added Andrew Rider, President of Pinnacle Senior Living LLC, Pennant’s senior living subsidiary. “These acquisitions underscore our focus on long-term growth while delivering exceptional care to our residents.”
About Pennant:
The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through home health and hospice agencies and senior living communities located throughout Arizona, California, Colorado, Connecticut, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.
Last Trade: | US$23.15 |
Daily Change: | 0.43 1.89 |
Daily Volume: | 255,100 |
Market Cap: | US$795.200M |
February 27, 2025 January 02, 2025 December 17, 2024 November 06, 2024 November 01, 2024 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load